Profile
William Rousmaniere is currently Chief Financial Officer at Analogic Corp.
since 2018 and also serves as Chief Financial Officer, Secretary & Treasurer at Lundbeck Seattle BioPharmaceuticals, Inc. Formerly, Mr. Rousmaniere was Director-Finance, Precision Motion & Technologies at Novanta, Inc. Education includes an undergraduate degree from Cornell University and an MBA from The Leonard N Stern School of Business.
William Rousmaniere active positions
| Companies | Position | Start |
|---|---|---|
| ANALOGIC CORPORATION | Director of Finance/CFO | 2018-06-21 |
| ALDER BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Former positions of William Rousmaniere
| Companies | Position | End |
|---|---|---|
| NOVANTA INC. | Corporate Officer/Principal | - |
Training of William Rousmaniere
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Analogic Corp.
Analogic Corp. Medical SpecialtiesHealth Technology Designs and manufactures computed tomography systems, magnetic resonance imaging power systems & airport checked baggage screening systems | Health Technology |
Novanta, Inc.
Novanta, Inc. Electronic Equipment/InstrumentsElectronic Technology Designs, develops, manufactures and sells precision photonic and motion control components | Electronic Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- William Rousmaniere
















